🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7148196

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7144867

    Anticancer glycoside compounds

    Northwestern University · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7141603

    Antitumor agents

    The Regents of the University of California · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7141661

    Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7141234

    Imaging of drug accumulation as a guide to antitumor therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7135303

    Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7125541

    Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

    THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7125969

    ETS-related gene overexpressed in human breast and epithelial cancers

    The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7122714

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7118738

    Recombinant pox virus for immunization against MUC1 tumor-associated antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7118747

    AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

    Pacific Northwest Biotechnology Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7119223

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7115360

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7112317

    Combined methods and compositions for tumor vasculature targeting and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7109188

    Methods and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7109303

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7108986

    Glypican-1 in human breast cancer

    The Regents of the University of California · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7105561

    Use of etodolac for the treatment of prostate cancer

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7101557

    Combined tissue factor methods for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7098306

    Method and compositions for treating hepatocellular cancer

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7084239

    Cancer peptides of NY-ESO-1/CAG-3

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7071168

    Anti-cancer compounds and methods related thereto

    The Regents of the University of Colorado · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7067653

    Porphyrin Based neuton capture agents for cancer therapy

    The Regents of the University of California · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7067109

    Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7067635

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7056503

    Enclosures housing cell-coated supports for treating tumors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7056908

    Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7053263

    Mouse models of human prostate cancer progression

    The Regents of the University of California · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7029652

    Method of treating tumors

    The Regents of the University of California · Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 7005424

    Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System · Granted Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 7001600

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6998513

    Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use

    The Regents of the University of California · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6998117

    Cancer treatment with retroviral vectors comprising wild-type p53

    The Board of Regents of the University of Texas System · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6998413

    Treatment of neoplasms with yujungamycins

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6995188

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6986891

    Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof

    Molecular Discoveries, L.L.C. · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6987193

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Jan 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6984619

    Method for protection against tumor metastasis formation

    The Board of Regents of the University of Texas System · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6984522

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6982168

    Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6979563

    Attenuation of tumor growth, metastasis and angiogenesis

    BioMarin Enzymes, Inc. · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6965017

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6960443

    Methods of detecting prostate stem cell antigen in cancer

    The Regents of the University of California · Granted Tue Nov 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6956145

    Mice models of human prostate cancer progression

    The Regents of the University of California · Granted Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6951917

    MHC-class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6949690

    Methods of assessing the effect of a gene of interest on human prostate cancer progression

    The Regents of the University of California · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6943245

    Tumor suppressor CAR-1

    The Board of Regents of the University of Texas System · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6929910

    Diagnostic and therapeutic methods using the H37 tumor suppressor gene

    The Regents of the University of California · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.